CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA (CCRCC) explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA (CCRCC) trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA (CCRCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to save kidneys in tough cancer cases
Disease control Recruiting nowThis study is testing if a combination of two drugs, pucotenlimab and vorolanib, can shrink kidney tumors before surgery. The goal is to make it possible for surgeons to remove the cancer while saving the healthy part of the kidney in patients where this is normally very difficul…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for advanced kidney cancer patients in experimental drug trial
Disease control Recruiting nowThis study is testing two new drug combinations for advanced kidney cancer that has spread or cannot be surgically removed. It will compare these experimental treatments against the current standard therapy in 120 patients who haven't received any previous cancer drugs. The main …
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE2 • Sponsor: Brian Rini • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New Two-Pronged attack on advanced cancers enters human testing
Disease control Recruiting nowThis study is testing a new experimental drug called REGN5678, which is designed to help the body's immune system find and attack cancer cells. It is being tested alone and in combination with an existing immunotherapy drug (cemiplimab) in patients with advanced prostate cancer o…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
First patients to receive new cancer drug targeting specific tumor mutations
Disease control Recruiting nowThis is the first study in people testing a new cancer drug called KO-2806. It aims to find a safe dose and see if the drug can help control advanced solid tumors, including certain lung, colorectal, pancreatic, and kidney cancers. The study will test the drug by itself and combi…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New cancer drug combo trial seeks to control advanced tumors
Disease control Recruiting nowThis study is testing a new drug called XL092, both by itself and in combination with other immunotherapy drugs, for people with advanced solid tumors that cannot be removed by surgery. The main goals are to find safe doses and see if the treatments can shrink tumors or slow thei…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Experimental Two-Pronged attack on tough cancers begins human testing
Disease control Recruiting nowThis early-stage study is testing a new, experimental immunotherapy drug called REGN10597, both by itself and combined with an existing drug (cemiplimab), in people with advanced solid tumors like melanoma and kidney cancer. The main goals are to find a safe dose and see if the t…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA (CCRCC)
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 02, 2026 15:25 UTC